Abstract:Background: Hepatocellular carcinoma (HCC) accounts for the majority of liver cancer, with the incidence and mortality rates increasing every year. Despite the improvement of clinical management, substantial challenges remain due to its high recurrence rates and short survival period. This study aimed to identify potential diagnostic and prognostic biomarkers in HCC through bioinformatic analysis. Methods: Datasets from GEO and TCGA databases were used for the bioinformatic analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were carried out by WebGestalt website and clusterProfiler package of R. The STRING database and Cytoscape software were used to establish the protein-protein interaction (PPI) network. The GEPIA website was used to perform expression analyses of the genes. The miRDB, miRWalk, and TargetScan were employed to predict miRNAs and the expression levels of the predicted miRNAs were explored via OncomiR database. LncRNAs were predicted in the StarBase and LncBase while circRNA prediction was performed by the circBank. ROC curve analysis and Kaplan-Meier (KM) survival analysis were performed to evaluate the diagnostic and prognostic value of the gene expression, respectively. Results: A total of 327 upregulated and 422 downregulated overlapping DEGs were identified between HCC tissues and noncancerous liver tissues. The PPI network was constructed with 89 nodes and 178 edges and eight hub genes were selected to predict upstream miRNAs and ceRNAs. A lncRNA/circRNA-miRNA-mRNA network was successfully constructed based on the ceRNA hypothesis, including five lncRNAs (DLGAP1-AS1, GAS5, LINC00665, TYMSOS, and ZFAS1), six circRNAs (hsa_circ_0003209, hsa_circ_0008128, hsa_circ_0020396, hsa_circ_0030051, hsa_circ_0034049, and hsa_circ_0082333), eight miRNAs (hsa-miR-150-5p, hsa-miR-19b-3p, hsa-miR-23b-3p, hsa-miR-26a-5p, hsa-miR-651-5p, hsa-miR-10a-5p, hsa-miR-214-5p and hsa-miR-486-5p), and five mRNAs (CDC6, GINS1, MCM4, MCM6, and MCM7). The ceRNA network can promote HCC progression via cell cycle, DNA replication, and other pathways. Clinical diagnostic and survival analyses demonstrated that the ZFAS1/hsa-miR-150-5p/GINS1 ceRNA regulatory axis had a high diagnostic and prognostic value. Conclusion: These results revealed that cell cycle and DNA replication pathway could be potential pathways to participate in HCC development. The ceRNA network is expected to provide potential biomarkers and therapeutic targets for HCC management, especially the ZFAS1/hsa-miR-150-5p/GINS1 regulatory axis.

Co-expression Analysis and Cerna Network Reveal Eight Novel Potential Lncrna Biomarkers in Hepatocellular Carcinoma.

Peer Review #1 of "Co-Expression Analysis and Cerna Network Reveal Eight Novel Potential Lncrna Biomarkers in Hepatocellular Carcinoma (V0.1)"

Transcriptome Sequencing of Hepatocellular Carcinoma Uncovers Multiple Types of Dysregulated Ncrnas

Transcriptome Profiling of Hepatocellular Carcinoma Uncovers Multi-Types of Dysregulated ncRNAs

Identification of lncRNA/circRNA-miRNA-mRNA ceRNA Network as Biomarkers for Hepatocellular Carcinoma

Identification of Long Noncoding RNAs Biomarkers in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma.

Expression Levels of Lncrnas Are Prognostic for Hepatocellular Carcinoma Overall Survival.

Identification of Lncrna Biomarkers in Hepatocellular Carcinoma by Comprehensive Analysis of the Lncrna-Mediated Cerna Network

Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma

Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations.

Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma

Genome-Wide Analysis of Prognostic Lncrnas, Mirnas, and Mrnas Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma

Integrative Analysis of Cerna Network Reveals Functional Lncrnas in Intrahepatic Cholangiocarcinoma

Network-Based Coexpression Analysis Identifies Functional and Prognostic Long Noncoding RNAs in Hepatocellular Carcinoma

Systematic analyses of a novel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma

Comprehensive Analysis Of Long Non-Coding Rna-Messenger Rna-Microrna Co-Expression Network Identifies Cell Cycle-Related Lncrna In Hepatocellular Carcinoma

Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma

A Comprehensive Genome‐wide Analysis of Long Noncoding RNA Expression Profile in Hepatocellular Carcinoma

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma

A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses

Identification of Novel Enhancer RNA Biomarkers and Corresponding Prognostic Signatures of Hepatocellular Carcinoma